Position in GH
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$850,820
+$404,396 QoQ
Shares Held
5,671
+17.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#332
of 593 holders
Holding Since
Jun 2025
5 quarters on record
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026KESTRA PRIVATE WEALTH SERVICES, LLC holds $17,747,028 across 12 Diagnostics & Research names. GH ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
15,254 | $7,647,745 | |
| 2 | DHR |
Danaher Corp /De/
|
13,658 | $2,601,575 | |
| 3 | ILMN |
Illumina, Inc.
|
8,599 | $1,511,962 | |
| 4 | DGX |
Quest Diagnostics Inc
|
6,940 | $1,470,933 | |
| 5 | GH |
Guardant Health, Inc.
This page
|
5,671 | $850,820 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
1,512 | $800,740 | |
| 7 | NTRA |
Natera, Inc.
|
2,703 | $733,729 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
2,851 | $646,578 |
All Filings in GH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $850,820 | 5,671 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $446,424 | 4,833 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $456,667 | 4,471 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $282,472 | 4,521 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $236,417 | 4,543 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||